Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

6 of 6 completed trials have results

Key Signals

2 recruiting6 with results

Enrollment Performance

Analytics

N/A
9(81.8%)
Early Phase 1
1(9.1%)
Phase 2
1(9.1%)
11Total
N/A(9)
Early Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)